Sources | Names Used |
---|---|
CTRPv2 | JQ-1:navitoclax (2:1 mol/mol) |
PharmacoGx | JQ-1:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MYOF | CTRPv2 | pan-cancer | AAC | -0.18 | 5e-06 |
mRNA | RAB13 | CTRPv2 | pan-cancer | AAC | -0.18 | 1e-05 |
mRNA | S100A11 | CTRPv2 | pan-cancer | AAC | -0.17 | 6e-06 |
mRNA | PXN | CTRPv2 | pan-cancer | AAC | -0.17 | 4e-06 |
mRNA | AURKA | CTRPv2 | pan-cancer | AAC | -0.17 | 5e-07 |
mRNA | CAST | CTRPv2 | pan-cancer | AAC | -0.17 | 5e-06 |
mRNA | TMED7-TICAM2 | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-05 |
mRNA | SGMS2 | CTRPv2 | pan-cancer | AAC | -0.17 | 8e-06 |
mRNA | CLIP1 | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-05 |
mRNA | ANLN | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-05 |